Net Loss of Parmax Pharma reported to Rs 0.73 crore in the quarter ended December 2025 as against net loss of Rs 0.39 crore during the previous quarter ended December 2024. Sales declined 31.05% to Rs 4.33 crore in the quarter ended December 2025 as against Rs 6.28 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended | ||
| Dec. 2025 | Dec. 2024 | % Var. | |
| Sales | 4.33 | 6.28 | -31 |
| OPM % | -4.39 | 1.91 | - |
| PBDT | -0.46 | 0.02 | PL |
| PBT | -0.73 | -0.39 | -87 |
| NP | -0.73 | -0.39 | -87 |
Powered by Capital Market - Live News